Global Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Research Report 2025

Publication ID:

PB503254141

Publication Date:

March 7, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Fermentation Engineering for Pharmaceutical Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Fermentation is a process used for cultivating micro-organisms or other organic material into important pharmaceuticals such as antibiotics, therapeutic proteins, enzymes and insulin. It is typically carried out in temperature-controlled tanks (fermenter) which require addition of nutrients at the correct concentration to maximize productivity of the organism of interest.
In China, 5 largest manufacturers of Fermentation Engineering for Pharmaceutical Drugs are Changchun GeneScience Pharmaceutical, 3SBio Inc, Shanghai Fosun Pharmaceutical, Sichuan Kelun Pharmaceutical and Shanghai Shyndec Pharmaceutical, which make up over 15%. Among them, Changchun GeneScience Pharmaceutical is the leader with about 6% market share. In terms of product type, Monoclonal Antibodies occupy the largest share of the total market, about 54%. And in terms of product Application, the largest application is Hospital, followed by Clinic.
This report aims to provide a comprehensive presentation of the global market for Fermentation Engineering for Pharmaceutical Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fermentation Engineering for Pharmaceutical Drugs.
The Fermentation Engineering for Pharmaceutical Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fermentation Engineering for Pharmaceutical Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fermentation Engineering for Pharmaceutical Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group
Segment by Type
Monoclonal Antibodies
Antibiotic
Insulin
Human Growth Hormone
Pharmaceutical Amino Acids
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fermentation Engineering for Pharmaceutical Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Antibiotic
1.2.4 Insulin
1.2.5 Human Growth Hormone
1.2.6 Pharmaceutical Amino Acids
1.2.7 Others
1.3 麻豆原创 by Application
1.3.1 Global Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Perspective (2020-2031)
2.2 Global Fermentation Engineering for Pharmaceutical Drugs Growth Trends by Region
2.2.1 Global Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Fermentation Engineering for Pharmaceutical Drugs Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Fermentation Engineering for Pharmaceutical Drugs Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Dynamics
2.3.1 Fermentation Engineering for Pharmaceutical Drugs Industry Trends
2.3.2 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Drivers
2.3.3 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Challenges
2.3.4 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fermentation Engineering for Pharmaceutical Drugs Players by Revenue
3.1.1 Global Top Fermentation Engineering for Pharmaceutical Drugs Players by Revenue (2020-2025)
3.1.2 Global Fermentation Engineering for Pharmaceutical Drugs Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Fermentation Engineering for Pharmaceutical Drugs Revenue
3.4 Global Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Concentration Ratio
3.4.1 Global Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fermentation Engineering for Pharmaceutical Drugs Revenue in 2024
3.5 Global Key Players of Fermentation Engineering for Pharmaceutical Drugs Head office and Area Served
3.6 Global Key Players of Fermentation Engineering for Pharmaceutical Drugs, Product and Application
3.7 Global Key Players of Fermentation Engineering for Pharmaceutical Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fermentation Engineering for Pharmaceutical Drugs Breakdown Data by Type
4.1 Global Fermentation Engineering for Pharmaceutical Drugs Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Fermentation Engineering for Pharmaceutical Drugs Forecasted 麻豆原创 Size by Type (2026-2031)
5 Fermentation Engineering for Pharmaceutical Drugs Breakdown Data by Application
5.1 Global Fermentation Engineering for Pharmaceutical Drugs Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Fermentation Engineering for Pharmaceutical Drugs Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size (2020-2031)
6.2 North America Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Country (2020-2025)
6.4 North America Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size (2020-2031)
7.2 Europe Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Country (2020-2025)
7.4 Europe Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size (2020-2031)
9.2 Latin America Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Changchun GeneScience Pharmaceutical
11.1.1 Changchun GeneScience Pharmaceutical Company Details
11.1.2 Changchun GeneScience Pharmaceutical Business Overview
11.1.3 Changchun GeneScience Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.1.4 Changchun GeneScience Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.1.5 Changchun GeneScience Pharmaceutical Recent Development
11.2 3SBio Inc
11.2.1 3SBio Inc Company Details
11.2.2 3SBio Inc Business Overview
11.2.3 3SBio Inc Fermentation Engineering for Pharmaceutical Drugs Introduction
11.2.4 3SBio Inc Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.2.5 3SBio Inc Recent Development
11.3 Shanghai Fosun Pharmaceutical
11.3.1 Shanghai Fosun Pharmaceutical Company Details
11.3.2 Shanghai Fosun Pharmaceutical Business Overview
11.3.3 Shanghai Fosun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.3.4 Shanghai Fosun Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.3.5 Shanghai Fosun Pharmaceutical Recent Development
11.4 Sichuan Kelun Pharmaceutical
11.4.1 Sichuan Kelun Pharmaceutical Company Details
11.4.2 Sichuan Kelun Pharmaceutical Business Overview
11.4.3 Sichuan Kelun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.4.4 Sichuan Kelun Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.4.5 Sichuan Kelun Pharmaceutical Recent Development
11.5 Shanghai Shyndec Pharmaceutical
11.5.1 Shanghai Shyndec Pharmaceutical Company Details
11.5.2 Shanghai Shyndec Pharmaceutical Business Overview
11.5.3 Shanghai Shyndec Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.5.4 Shanghai Shyndec Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.5.5 Shanghai Shyndec Pharmaceutical Recent Development
11.6 CSPC Pharmaceutical Group
11.6.1 CSPC Pharmaceutical Group Company Details
11.6.2 CSPC Pharmaceutical Group Business Overview
11.6.3 CSPC Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Introduction
11.6.4 CSPC Pharmaceutical Group Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.6.5 CSPC Pharmaceutical Group Recent Development
11.7 United Laboratories International Holdings
11.7.1 United Laboratories International Holdings Company Details
11.7.2 United Laboratories International Holdings Business Overview
11.7.3 United Laboratories International Holdings Fermentation Engineering for Pharmaceutical Drugs Introduction
11.7.4 United Laboratories International Holdings Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.7.5 United Laboratories International Holdings Recent Development
11.8 Tonghua Dongbao Pharmaceutical
11.8.1 Tonghua Dongbao Pharmaceutical Company Details
11.8.2 Tonghua Dongbao Pharmaceutical Business Overview
11.8.3 Tonghua Dongbao Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.8.4 Tonghua Dongbao Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.8.5 Tonghua Dongbao Pharmaceutical Recent Development
11.9 Joincare Pharmaceutical Group
11.9.1 Joincare Pharmaceutical Group Company Details
11.9.2 Joincare Pharmaceutical Group Business Overview
11.9.3 Joincare Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Introduction
11.9.4 Joincare Pharmaceutical Group Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.9.5 Joincare Pharmaceutical Group Recent Development
11.10 North China Pharma
11.10.1 North China Pharma Company Details
11.10.2 North China Pharma Business Overview
11.10.3 North China Pharma Fermentation Engineering for Pharmaceutical Drugs Introduction
11.10.4 North China Pharma Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.10.5 North China Pharma Recent Development
11.11 Anhui Anke Biotechnology
11.11.1 Anhui Anke Biotechnology Company Details
11.11.2 Anhui Anke Biotechnology Business Overview
11.11.3 Anhui Anke Biotechnology Fermentation Engineering for Pharmaceutical Drugs Introduction
11.11.4 Anhui Anke Biotechnology Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.11.5 Anhui Anke Biotechnology Recent Development
11.12 Gan and Lee Pharmaceuticals
11.12.1 Gan and Lee Pharmaceuticals Company Details
11.12.2 Gan and Lee Pharmaceuticals Business Overview
11.12.3 Gan and Lee Pharmaceuticals Fermentation Engineering for Pharmaceutical Drugs Introduction
11.12.4 Gan and Lee Pharmaceuticals Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.12.5 Gan and Lee Pharmaceuticals Recent Development
11.13 Shandong Kexing Bioproducts
11.13.1 Shandong Kexing Bioproducts Company Details
11.13.2 Shandong Kexing Bioproducts Business Overview
11.13.3 Shandong Kexing Bioproducts Fermentation Engineering for Pharmaceutical Drugs Introduction
11.13.4 Shandong Kexing Bioproducts Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.13.5 Shandong Kexing Bioproducts Recent Development
11.14 Harbin Pharmaceutical Group
11.14.1 Harbin Pharmaceutical Group Company Details
11.14.2 Harbin Pharmaceutical Group Business Overview
11.14.3 Harbin Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Introduction
11.14.4 Harbin Pharmaceutical Group Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2020-2025)
11.14.5 Harbin Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.